Region: Global
Category: Diagnostics

Global Diagnostics

(6,742 reports matching your criteria)
  • Coagulation Testing

    ... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More

  • 3D Medical Imaging

    ... at a CAGR of 6.1% over the analysis period 2024-2030. CT Devices, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$8.9 Billion by the end of ... Read More

  • Aptamers

    ... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More

  • Automated Liquid Handling Systems

    ... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More

  • Urinalysis

    ... 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More

  • Veterinary Diagnostics

    ... CAGR of 7.0% over the analysis period 2024-2030. Veterinary Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the ... Read More

  • Zika Virus Testing

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More

  • X-Ray Photoelectron Spectroscopy

    ... at a CAGR of 4.8% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by the end of ... Read More

  • Veterinary CT Scanners

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Stationary Multi Slice CT Scanners, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$175.7 Million by ... Read More

  • Rapid Medical Diagnostic Kits

    ... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More

  • Veterinary Ultrasound Scanners

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Portable Ultrasound Scanners, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$327.4 Million by the end ... Read More

  • Cerebral Angiography

    ... CAGR of 6.6% over the analysis period 2024-2030. Magnetic Resonance Angiography Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$36.8 Million by the end of ... Read More

  • Microtomes

    ... 6.0% over the analysis period 2024-2030. Microtome Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth ... Read More

  • Global XRD Instruments Market Insights, Forecast to 2031

    ... US & Canada market for XRD Instruments is estimated to increase from $ 185.74 million in 2024 to reach $ 248.93 million by 2031, at a CAGR of 3.97% during the forecast period of 2025 ... Read More

  • Particle Therapy

    ... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More

  • Medical X-Ray

    ... CAGR of 5.1% over the analysis period 2024-2030. Digital Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$13.5 Billion by the end of the analysis ... Read More

  • Prenatal Diagnostics

    ... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis ... Read More

  • Hematology Instruments and Reagents

    ... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More

  • High Content Screening (HCS)

    ... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the ... Read More

  • Advanced (3D/4D) Visualization Systems

    ... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. MRI Modality, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.7 Billion by the ... Read More

  • Circulating Tumor Cell (CTC) Diagnostics

    ... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More

  • Rabies Diagnostics

    ... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT) Method, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end ... Read More

  • Imaging Agents

    ... CAGR of 4.5% over the analysis period 2024-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More

  • Mammography Equipment

    ... CAGR of 6.8% over the analysis period 2024-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.1 Billion by the end of ... Read More

  • Cholesterol Testing

    ... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings